Webinar Series: Leveraging Different Sectors to Address the Youth Mental Health Crisis According to recent data from CDC, poor mental health symptoms and suicidal ideation are on the rise for high ...
On April 12, 2023, ASTHO released a statement applauding the Office of National Drug Control Policy’s announcement designating fentanyl adulterated or associated with xylazine as an emerging drug ...
ASTHO Applauds Administration's Commitment to Combat the Opioid Epidemic ARLINGTON, VA—Michael Fraser, executive director of ASTHO, issued the following response to HHS Secretary Tom Price’s ...
On Jan. 30, 2023, ASTHO released a statement commending the FDA on a new proposal to conduct individual risk assessments for blood donors, a policy that reflects the best available science while not ...
The opioid epidemic has exacerbated the shortage of board-certified forensic pathologists, presenting a major workforce challenge for public health systems.
On Oct. 4, 2023, ASTHO, CDC, the Center for Law and Social Policy, and Mental Health America released a framework for public health leaders with effective strategies to improve mental health and ...
Nation’s Public Health Officials Urge Americans to Stop Vaping ARLINGTON, VA—The Association of State and Territorial Health Officials (ASTHO) issued the following statement in response to the ...
Panel of State Public Health Officials Testify on Lung Disease Outbreak WASHINGTON—Today, four state health officials are testifying on a panel before the House Energy and Commerce Subcommittee on ...
ASTHO Commends the Surgeon General Advisory about Marijuana Use on the Developing Brain ARLINGTON, VA—Michael Fraser, Chief Executive Officer of the Association of State and Territorial Health ...
ASTHO Member and Delaware Health Official Karyl Rattay Testifies on Nation’s Opioid Epidemic ARLINGTON, VA—Karyl Rattay, MD, MS, director and state health officer at the Delaware Division of Public ...